Literature DB >> 811637

Absorption of two antibacterial drugs, cephalexin and co-trimoxazole, in malabsorption syndromes.

R L Parsons, G M Paddock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811637     DOI: 10.1093/jac/1.suppl_3.59

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.

Authors:  R E Schneider; J Babb; H Bishop; M Mitchard; A M Hoare
Journal:  Br Med J       Date:  1976-10-02

2.  Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.

Authors:  K M Deppermann; H Lode; G Höffken; G Tschink; C Kalz; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors:  J Prandota; I J Smith; B C Hilman; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 5.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 7.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

8.  Study of the bioavailability of pindolol in malabsorption syndromes.

Authors:  D Evard; J P Aubry; Y Le Quintrec; G Cheymol; A Cheymol
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.